Beware: steep gradient ahead.

One criticism of stereotactic body radiation (SBRT), and sublobar resections, for NSCLC is the potential for occult disease in the involved lobe. Not only could this be a source of marginal failures, it could even lead to subsequent regional or distant metastases. One of the priorities of lung SBRT is a rapid dose fall-off outside the target to spare healthy heart and lung function. This study takes a novel look at whether rapid dose fall-off also spares extra-target tumor control. Using a large cohort (n=217) of patients with Stage I NSCLC treated with SBRT from two institutions, the mean dose within a 3 cm shell surrounding the target volume was calculated. In patients who received a mean dose of at least 20.8 Gy to this region, the rate of later distant disease was 5%. In patients with a mean periphery dose <20.8 Gy, that rate was...60%. The authors make two interesting hypotheses here. Moderate dose outside the target may 1) kill potentially metastatic tumor clones and/or 2) contribute to an immunogenic abscopal effect. TBL: Controlling moderate SBRT dose outside the primary target volume for NSCLC may adversely impact risk of distant failure. | Diamant, Radiother Oncol 2018


  1. When you need to investigate someone for legal or personal reasons, detect infidelity, put a tracker on your kids and loved ones, retrieve stolen digital assets or data, Mcrae Investigation Firm can help. They have access to vast information, technical skills, millions of records, proprietary tools, and unique methods. Tap in mcraespy(at) for a free consultation.


Post a Comment

Popular Posts